Efficacy and Safety of Vatelizumab in Patients Who Completed Treatment in Study DRI13839

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2014
Primary Objective: To assess the long-term safety of vatelizumab in MS patients Secondary Objective: To assess the long-term efficacy of vatelizumab
Epistemonikos ID: e91753f96a0c449eef2281a9268de3cdfa6196b2
First added on: Mar 31, 2022